newsfilter
← Latest News
Business Wire·

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

Will Add Two Independent Directors with MedTech and Operations Experience to be Named at a Later Date Reconstituted Operations and Innovation Committee Will Expand Mandate to Oversee Operations, Quality and Technical